Adipocyte biology: It is time to upgrade to a new model.
Hanél Sadie-Van GijsenPublished in: Journal of cellular physiology (2018)
Globally, the obesity pandemic is profoundly affecting quality of life and economic productivity, but efforts to address this, especially on a pharmacological level, have generally proven unsuccessful to date, serving as a stark demonstration that our understanding of adipocyte biology and pathophysiology is incomplete. To deliver better insight into adipocyte function and obesity, we need improved adipocyte models with a high degree of fidelity in representing the in vivo state and with a diverse range of experimental applications. Adipocyte cell lines, especially 3T3-L1 cells, have been used extensively over many years, but these are limited in terms of relevance and versatility. In this review, I propose that primary adipose-derived stromal/stem cells (ASCs) present a superior model with which to study adipocyte biology ex vivo. In particular, ASCs afford us the opportunity to study adipocytes from different, functionally distinct, adipose depots and to investigate, by means of in vivo/ex vivo studies, the effects of many different physiological and pathophysiological factors, such as age, body weight, hormonal status, diet and nutraceuticals, as well as disease and pharmacological treatments, on the biology of adipocytes and their precursors. This study will give an overview of the characteristics of ASCs and published studies utilizing ASCs, to highlight the areas where our knowledge is lacking. More comprehensive studies in primary ASCs will contribute to an improved understanding of adipose tissue, in healthy and dysfunctional states, which will enhance our efforts to more successfully manage and treat obesity.
Keyphrases
- adipose tissue
- insulin resistance
- high fat diet
- high fat diet induced
- metabolic syndrome
- stem cells
- fatty acid
- weight loss
- type diabetes
- body weight
- polycystic ovary syndrome
- skeletal muscle
- sars cov
- healthcare
- bone marrow
- multidrug resistant
- weight gain
- body mass index
- cell death
- cell proliferation
- case control
- signaling pathway
- mesenchymal stem cells